We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSTO
701
DELISTED
Histogen Inc. Common Stock
HSTO
$2.38M 0.01%
+1,463
New +$3.06M
HOG icon
702
Harley-Davidson
HOG
$2.87B
$2.38M 0.01%
35,734
+11,835
+50% +$783K
UTHR icon
703
United Therapeutics
UTHR
$21.5B
$2.37M 0.01%
25,170
-67,330
-73% -$6.89M
ADI icon
704
Analog Devices
ADI
$175B
$2.37M 0.01%
44,500
+1,330
+3% +$67K
PCG icon
705
PG&E
PCG
$29B
$2.36M 0.01%
54,700
-104,438
-66% -$4.43M
CYH icon
706
Community Health Systems
CYH
$419M
$2.36M 0.01%
72,871
-160,623
-69% -$5.3M
GRPN icon
707
Groupon
GRPN
$762M
$2.35M 0.01%
15,000
-14,100
-48% -$2.74M
MATV icon
708
Mativ Holdings
MATV
$656M
$2.34M 0.01%
54,870
-28,374
-34% -$1.29M
UNF icon
709
Unifirst Corp
UNF
$4.83B
$2.34M 0.01%
21,260
+10,760
+102% +$1.17M
CBL
710
DELISTED
CBL& Associates Properties, Inc.
CBL
$2.33M 0.01%
131,500
+79,000
+150% +$1.37M
ICFI icon
711
ICF International
ICFI
$1.59B
$2.33M 0.01%
58,600
+4,320
+8% +$158K
TLM
712
DELISTED
TALISMAN ENERGY INC
TLM
$2.33M 0.01%
233,759
+209,800
+876% +$2.23M
EWN icon
713
iShares MSCI Netherlands ETF
EWN
$636M
$2.32M 0.01%
88,693
WNR
714
DELISTED
Western Refining Inc
WNR
$2.32M 0.01%
60,000
-19,800
-25% -$778K
WTFC icon
715
Wintrust Financial
WTFC
$10.2B
$2.3M 0.01%
47,300
+4,670
+11% +$215K
BCO icon
716
Brink's
BCO
$4.48B
$2.29M 0.01%
80,400
+10,200
+15% +$320K
MKC icon
717
McCormick & Company Non-Voting
MKC
$13.4B
$2.28M 0.01%
63,460
-800
-1% -$26.9K
BFH icon
718
Bread Financial
BFH
$4.14B
$2.26M 0.01%
10,390
+4,511
+77% +$969K
EA
719
DELISTED
Electronic Arts
EA
$2.25M 0.01%
77,700
-639,150
-89% -$17.1M
IMKTA icon
720
Ingles Markets
IMKTA
$1.57B
$2.25M 0.01%
94,555
-49,562
-34% -$1.22M
VALE.P
721
DELISTED
Vale S A
VALE.P
$2.25M 0.01%
180,804
-4,042
-2% -$49.6K
CCOI icon
722
Cogent Communications
CCOI
$473M
$2.24M 0.01%
+63,125
New +$2.47M
PAG icon
723
Penske Automotive Group
PAG
$14.2B
$2.24M 0.01%
52,346
-13,400
-20% -$582K
TGA
724
DELISTED
Transglobe Energy Corp
TGA
$2.23M 0.01%
291,400
-101,900
-26% -$779K
ABM icon
725
ABM Industries
ABM
$2.93B
$2.21M 0.01%
77,000
-6,800
-8% -$189K

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.